ACS Combinatorial Science
Research Article
M.; Fuentes-Pesquera, A. R.; Greenberger, L. M. Synthesis and
Evaluation of Pyrazolo[3,4-b]pyridine CDK1 Inhibitors as Anti-tumor
Agents. Bioorg. Med. Chem. Lett. 2007, 17, 4297−4302. (b) Ye, Q.;
Cao, J.; Zhou, X.; Lv, D.; He, Q.; Yang, B.; Hu, Y. Synthesis and
Evaluation of Novel 7-Azaindazolyl-indolyl-maleimide Derivatives as
Antitumor Agents and Protein Kinase C Inhibitors. Bioorg. Med. Chem.
(19) Crosignani, S.; Page, P.; Missotten, M.; Colovray, V.; Cleva, C.;
Arrighi, J. F.; Atherall, J.; Macritchie, J.; Martin, T.; Humbert, Y.;
Gaudet, M.; Pupowicz, D.; Maio, M.; Pittet, P. A.; Golzio, L.;
Giachetti, C.; Rocha, C.; Bernardinelli, G.; Filinchuk, Y.; Scheer, A.;
Schwarz, M. K.; Chollet, A. Discovery of a New Class of Potent,
Selective, and Orally Bioavailable CRTH2 (DP2) Receptor Antago-
nists for the Treatment of Allergic Inflammatory Diseases. J. Med.
Chem. 2008, 51, 2227−2243.
2
(
009, 17, 4763−4772.
6) Leal, B.; Afonso, I. F.; Rodrigues, C. R.; Abreu, P. A.; Garrett, R.;
Pinheiro, L. C. S.; Azevedo, A. R.; Borges, J. C.; Vegi, P. F.; Santos, C.
C. C.; da Silveira, F. C. A.; Cabral, L. M.; Frugulhetti, I. C. P. P.;
Bernardino, A. M. R.; Santos, D. O.; Castro, H. C. Antibacterial Profile
Against Drug-resistant Staphylococcus Epidermidis Clinical Strain and
Structure−Activity Relationship Studies of 1H-Pyrazolo[3,4-b]pyridine
and Thieno[2,3-b]pyridine Derivatives. Bioorg. Med. Chem. 2008, 16,
(20) (a) Usui, T.; Kondoh, M.; Cui, C.-B.; Mayumi, T.; Osada, H.;
Tryprostatin, A. a Specific and Novel Inhibitor of Microtubule
Assembly. Biochem. J. 1998, 333, 543−548. (b) Cui, C. B.; Kakeya, H.;
Osada, H.; Spirotryprostatin, B. a Novel Mammalian Cell Cycle
Inhibitor Produced by Aspergillus Fumigatus. J. Antibiot. 1996, 49,
832−835.
8
(
196−8204.
(21) (a) Jossang, A.; Jossang, P.; Hadi, H. A.; Sevenet, T.; Horsfiline,
B. B. Horsfiline, an Oxindole Alkaloid from Horsfieldia Superba. J. Org.
Chem. 1991, 56, 6527−6530. (b) Edmonson, S.; Danishefsky, S. J.;
Sepp-Lorenzino, L.; Rosen, N. Total Synthesis of Spirotryprostatin A,
Leading to the Discovery of Some Biologically Promising Analogues. J.
Am. Chem. Soc. 1999, 121, 2147−2155. (c) Cui, C. -B.; Kakeya, H.;
Osada, H.; Spirotryprostatin, B. a Novel Mammalian cell cycle
inhibitor produced by Aspergillus fumigatus. J. Antibiot. 1996, 49,
832−835. (d) Carroll, W. A.; Grieco, P. A. Biomimetic Total Synthesis
of Pseudotabersonine: a Novel Oxindole-based Approach to
Construction of Aspidosperma Alkaloids. J. Am. Chem. Soc. 1993,
115, 1164−1165. (e) Anderton, N.; Cockrum, P. A.; Colegate, S. M.;
Edgar, J. A.; Flower, K.; Vit, I. Willing, R. I. Oxindoles from Phalaris
Coerulescens. Phytochemistry 1998, 48, 437−439. (f) Colegate, S. M.;
Anderton, N.; Edgar, J.; Bourke, C. A.; Oram, R. N. Suspected Blue
Canary Grass (Phalaris coerulescens) Poisoning of Horses. Aust. Vet. J.
1999, 77, 537−538. (g) Sakai, S.; Aimi, N.; Yamaguchi, K.; Ohhira, H.;
Hori, K.; Haginiwa, J. Gardneria Alkaloids-IX Structures of
Chitosenine and Three Other Minor Bases: From Gardneria
Multiflora Makino. Tetrahedron Lett. 1975, 16, 715−718. (h) Elderfield,
R. C.; Gilman, R. E. Alkaloids of Alstonia Muelleriana. Phytochemistry
1972, 11, 339−343.
(22) (a) Shakibaei, G. I.; Feiz, A.; Khavasi, H. R.; Abolhasani-Sooraki,
A.; Bazgir, A. Simple Three-component Method for the Synthesis of
Spiroindeno[1,2-b]pyrido[2,3-d]pyrimidine-5,3′-indolines. ACS Comb.
Sci. 2011, 13, 96−99. (b) Jadidi, K.; Ghahremanzadeh, R.; Bazgir, A.
Spirooxindoles: Reaction of 2,6-Diaminopyrimidin-4(3H)-one and
Isatins. Tetrahedron 2009, 65, 2005−2009. (c) Dabiri, M.; Azimi, S. K.;
Khavasi, H. R.; Bazgir, A. A Novel Reaction of 6-Amino-uracils and
Isatins. Tetrahedron 2008, 64, 7307−7311. (d) Chen, T.; Xu, X. -P.; Ji,
S. -J. Novel, One-Pot, Three-Component Route to Indol-3-yl
Substituted Spirooxindole Derivatives. J. Comb. Chem. 2010, 12,
659−663. (e) Chen, H.; Shi, D. Efficient One-Pot Synthesis of Novel
Spirooxindole Derivatives via Three-Component Reaction in Aqueous
Medium. J. Comb. Chem. 2010, 12, 571−576. (f) Ghahremanzadeh, R.;
Sayyafi, M.; Ahadi, S.; Bazgir, A. Novel One-Pot, Three-Component
Synthesis of Spiro[Indoline-pyrazolo[4′,3′:5,6]pyrido[2,3-d]-
pyrimidine]trione Library. J. Comb. Chem. 2009, 11, 393−396.
(g) Ahadi, S.; Ghahremanzadeh, R.; Mirzaei, P.; Bazgir, A. Synthesis
of Spiro[benzopyrazolonaphthyridine-indoline]-diones and Spiro-
[chromenopyrazolo Pyridine-indoline]-diones by One-pot, Three-
component Methods in Water. Tetrahedron 2009, 65, 9316−9321.
(h) Rajabi Khorami, A.; Faraji, F.; Bazgir, A. Ultrasound-assisted
Three-Component Synthesis of 3-(5-Amino-1H-pyrazol-4-yl)-3-(2-
hydroxy-4,4-dimethyl-6-oxocyclohex-1-enyl)indolin-2-ones in Water.
Ultrason. Sonochem. 2010, 17, 587−591. (i) Arya, A. K.; Kumar, M.
Base Catalyzed Multi-component Synthesis of Spiroheterocycles with
Fused Heterosystems. Mol. Diversity 2011, 15, 781−789.
7) Bharate, S. B.; Mahajan, T. R.; Gole, Y. R.; Nambiar, M.; Matan,
T. T.; Kulkarni-Almeida, A.; Balachandran, S.; Junjappa, H.;
Balakrishnan, A.; Vishwakarma, R. A. Synthesis and Evaluation of
Pyrazolo[3,4-b]pyridines and its Structural Analogues as TNF-α and
IL-6 Inhibitors. Bioorg. Med. Chem. 2008, 16, 7167−7176.
(
8) Dias, L. R. S.; Santos, M. B.; de Albuquerque, S.; Castro, H. C.;
de Souza, A. M. T.; Freitas, A. C. C.; DiVaio, M. A. V.; Cabral, L. M.;
Rodrigues, C. R. Synthesis, in Vitro Evaluation, and SAR Studies of a
Potential Antichagasic 1H-Pyrazolo[3,4-b]pyridine Series. Bioorg. Med.
Chem. 2007, 15, 211−219.
(
9) Chioua, M.; Samadi, A.; Soriano, E.; Lozach, O.; Meijer, L.;
Marco-Contelles, J. Synthesis and Biological Evaluation of 3,6-
Diamino-1H-pyrazolo[3,4-b]pyridine Derivatives as Protein Kinase
Inhibitors. Bioorg. Med. Chem. Lett. 2009, 19, 4566−4569.
(
10) Huang, S.; Lin, R.; Yu, Y.; Lu, Y.; Connolly, P.; Chiu, G.; Li, S.;
Emanuel, S.; Middleton, S. Synthesis of 3-(1H-Benzimidazol-2-yl)-5-
isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a Potent Cyclin Dependent
Kinase 1 (CDK1) Inhibitor. Bioorg. Med. Chem. Lett. 2007, 17, 1243−
1245.
(
11) Revesz, L.; Blum, E.; Di Padova, F. E.; Buhl, T.; Feifel, R.; Gram,
H.; Hiestand, P.; Manning, U.; Neumann, U.; Rucklin, G.
Pyrazoloheteroaryls: Novel p38α MAP Kinase Inhibiting Scaffolds
with Oral Activity. Bioorg. Med. Chem. Lett. 2006, 16, 262−266.
(
12) Witherington, J.; Bordas, V.; Gaiba, A.; Garton, N. S.; Naylor,
A.; Rawlings, A. D.; Slingsby, B. P.; Smith, D. G.; Takle, A. K.; Ward,
R. W. 6-Aryl-pyrazolo[3,4-b]pyridines: Potent Inhibitors of Glycogen
Synthase Kinase-3 (GSK-3). Bioorg. Med. Chem. Lett. 2003, 13, 3055−
3057.
(
13) Mitchell, C. J.; Ballantine, S. P.; Coe, D. M.; Cook, C. M.;
Delves, C. J.; Dowle, M. D.; Edlin, C. D.; Hamblin, J. N.; Holman, S.;
Johnson, M. R.; Jones, P. S.; Keeling, S. E.; Kranz, M.; Lindvall, M.;
Lucas, F. S.; Neu, M.; Solanke, Y. E.; Somers, D. O.; Trivedi, N. A.;
Wiseman, J. O. Pyrazolopyridines as Potent PDE4B Inhibitors: 5-
Heterocycle SAR. Bioorg. Med. Chem. Lett. 2010, 20, 5803−5806.
(
14) Saggar, S.; Sisko, J.; Tucker, T.; Tynebor, R.; Su, D.; Anthony,
N. Preparation of Heterocyclic Phenoxy Compounds as HIV Reverse
Transcriptase Inhibitors. U.S. Patent Appl. US 2,007,021,442, 2007,
Chem. Abstr. 2007, 146, 163149.
(
15) (a) Da Silva, J. F. M.; Garden, S. J.; Pinto, A. C. The Chemistry
of Isatins: a Review from 1975 to. 1999. J. Braz. Chem. Soc. 2001, 12,
73−324. (b) Abdel-Rahman, A. H.; Keshk, E. M.; Hanna, M. A.; El-
2
Bady, Sh. M. Synthesis and Evaluation of Some New Spiro Indoline-
based Heterocycles as Potentially Active Antimicrobial Agents. Bioorg.
Med. Chem. 2004, 12, 2483−2488.
(
16) Kornet, M. J.; Thio, A. P. Oxindole-3-spiropyrrolidines and
piperidines. Synthesis and Local Anesthetic Activity. J. Med. Chem.
976, 19, 892−898.
17) Okita, T.; Isobe, M. Synthesis of the Pentacyclic Intermediate
-
1
(
(23) Rahmati, A. Synthesis of 4-Aryl-3-methyl-6-oxo-4,5,6,7-tetrahy-
dro-2H-pyrazolo[3,4-b]pyridine-5-carbonitrile via a One-pot, Three-
component Reaction. Tetrahedron Lett. 2010, 51, 2967−2970.
(24) X-ray data for 4{1,1,1}: (C H N O ), M = 293.29 g/mol,
for Dynemicin and Unusual Formation of Spiro-oxindole Ring.
Tetrahedron 1994, 50, 11143−11152.
(
18) Rosenmond, P.; Hosseini-Merescht, M.; Bub, C. Ein Einfacher
15
11
5
2
Zugang zu den Tetracyclischen Vorla
Secoyohimbane, Strychnos und Oxindolalkaloide. Liebigs Ann. Chem.
994, 151−154.
̈
ufern der Hetero- und
monoclinic system, space group C2/c, a = 24.154(8) Å, b =
3
7.5150(15) Å, c = 16.506(5) Å, β = 110.27(2)°, V = 2810.6(14) Å ,
−
3
−1
1
Z = 8, Dc = 1.386 g cm , μ(Mo Kα)= 0.097 mm , crystal dimension:
6
63
dx.doi.org/10.1021/co300047j | ACS Comb. Sci. 2012, 14, 657−664